F polymerase developed by Alkor Bio Group is enzyme allowing to amplify the DNA-fragments for more than 10000 bp with high fidelity and speed.

In April 2016 Alkor Bio Group's Laboratory of Allergology completed the development and transferred to the production 15 new allergens, including 1 recombinant allergen component of carrot - rDau c 1 Carrot.

In April Alkor Bio Group has received a grant of Foundation for Assistance to Small Innovative Enterprises (FASIE/Bortnik Fund) in the competition “Commercialization III” for the project “Genetic diagnostic of cystic fibrosis based on microchip-technology”.

In march Alkor Bio’s Laboratory of Molecular Diagnostics has finished development of the kits for  mutations determination in the CYP21A2 gene. Approximately 90% of the classic forms of CAH, salt-wasting and simple virilizing, are due to mutations in the CYP21A2 gene causing the disorder in functioning of the 21-hudroxylasa enzyme.

In the middle of February Alkor Bio’s Laboratory of Molecular Diagnostics finished the development of new express protocol for DNA extraction with “Express-DNA-Bio” kit production of Alkor Bio Co. Ltd. This allow extract DNA from whole blood and tissue materials without difficult prior sample preparation.

In February of 2016 Alkor Bio Group’s Laboratory of Allergology completed the development and transferred to the production 12 new allergens and has planned the development of new products for in vitro allergen diagnostics.